News
I live with lacrimal gland failure, corneal neuralgia, and meibomian gland dysfunction—also known as dry eye. These diseases ...
Spun off from Novartis in 2019, Alcon is betting on new product launches to accelerate sales growth in the second half of ...
Millions of Americans suffer from dry eye disease, an often-overlooked condition that can significantly impact daily life. In ...
Dry Eye Syndrome (DES) is increasingly prevalent due to digital screen usage and environmental factors, affecting various age ...
The FDA has approved Tryptyr (acoltremon) as the first TRPM8-targeting eye drop for dry eye disease, stimulating natural tear ...
Dry eye syndrome, a condition affecting millions of Americans each year, continues to present a frustrating challenge for ...
In this episode of CT BUZZ, Reporter Jillian Andrews sat down with Dr. Donald Higgins, Optometrist and Medical Director of ...
Tear film stability, tear production, ocular surface health, and symptoms were all significantly improved with the use of ...
Alcon, a global eye care company known for products such as Systane and GenTeal Tears, plans to launch Tryptyr in the U.S.
Aromatase inhibitors Medications like letrozole (Femara) can lower the risk of breast cancer returning after treatment, but may increase the risk of dry eye, possibly due to a lower meibum production.
Discover the surprising connection between dry eyes and headaches, plus practical solutions for breaking the pain cycle that ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results